Indications and uses
prevents and treats nausea, vomiting or dizziness associated with motion sickness.
prevents and treats nausea, vomiting or dizziness associated with motion sickness.
dosage should be taken one hour before travel starts adults and children 12 years and over take 2 or 4 tablets once daily or as directed by a doctor
store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].
Meclizine HCl, USP 12.5 mg
Antiemetic
prevents and treats nausea, vomiting or dizziness associated with motion sickness.
Do not use in children under 12 years of age unless directed by a doctor.
Do not take this product, unless directed by a doctor, if you have
Do not take this product if you are
taking sedatives or tranquilizers, without first consulting your doctor.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
dosage should be taken one hour before travel starts
| adults and children 12 years and over | take 2 or 4 tablets once daily or as directed by a doctor |
colloidal silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, microcrystalline cellulose
Call 1-844-474-7464 Monday to Friday 8 AM - 5 PM ET
Manufactured by:
Unique Pharmaceutical Laboratories
(A Div. of J.B.Chemicals &
Pharmaceuticals Ltd.),
Mumbai 400 030, India
Mfg. Lic. No.: G/1430
Distributed by:
Rising Pharma Holdings, Inc.
East Brunswick, NJ 08816
Issued: 02/2024
138528
NDC 57237-333-01
Meclizine Hydrochloride Tablets, USP
12.5 mg
100 Tablets
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57237-333-01 | Meclizine HCl | 100 in 1 BOTTLE | TABLET | 100 | 3 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57237-333-01 | EA - Each | 57237-333 | 4687908e-e794-453c-adee-a9b75d405bc3 | 1 | 2024-11-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57237-333 | 57237-333-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CROSPOVIDONE | 2S7830E561 | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meclizine HCl | MECLIZINE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | acdf636c-66f1-4a1f-87a8-786f51d75708 | 2024-11-13 | Warnings | 57237-333-01 57237-333 57237033301 f603203c-84a4-4b41-a244-cff913e5c2e0 acdf636c-66f1-4a1f-87a8-786f51d75708 |
Adverse event summaries are temporarily unavailable. Other product information remains available.